Amino Acid Sequences within the α Subunit of Integrin αMβ2(Mac-1) Critical for Specific Recognition of C3bi
- 1 June 1999
- journal article
- research article
- Published by American Chemical Society (ACS) in Biochemistry
- Vol. 38 (25) , 8064-8071
- https://doi.org/10.1021/bi990141h
Abstract
Phagocytosis of opsonized particles by neutrophils and monocytes plays a central role in host defense mechanisms against foreign pathogens. This process depends on the interaction between C3bi, a degradation product derived from activation of the complement system, and the αMβ2 (CD11b/CD18, Mac-1) receptor, the major integrin on neutrophils. Previous studies had established a central role for the I domain, a stretch of ∼200 amino acids within the αM subunit in the binding of C3bi, as well as many other αMβ2 ligands. The present study was undertaken to establish the molecular basis of C3bi recognition by αMβ2. The strategy employed the use of a series of mutant receptors in which short segments of the I domain of αM were switched to the corresponding segments of αL, which is structurally very similar but does not bind C3bi. We report three major findings: (1) The C3bi binding pocket is composed of three regions, P147−R152, P201−K217, and K245−R261 of αM, which surround the cation binding site within the MIDAS motif of the I domain. (2) Within the latter segment, K245 plays a critical role in mediating C3bi binding to αMβ2. Mutation of K245 to Ala significantly reduced C3bi binding but had no effect on binding of another αMβ2 I domain ligand, NIF. (3) Blocking of C3bi binding to αMβ2 by monoclonal antibodies is achieved through two different mechanisms: direct competition for the ligand binding site or induction of conformational changes. Overall, these studies support the hypothesis that many of the ligands of αMβ2 bind to overlapping but not identical sites within the I domain. Although the same short structural segments within the I domain may be involved in binding, different amino acids within these segments may contact different ligands.Keywords
This publication has 15 references indexed in Scilit:
- The Integrin α1 A-domain Is a Ligand Binding Site for Collagens and LamininJournal of Biological Chemistry, 1997
- Contributions of the I and EF Hand Domains to the Divalent Cation-dependent Collagen Binding Activity of the α2β1 IntegrinPublished by Elsevier ,1997
- Activated Polymorphonuclear Leukocytes Induce Constriction of Canine Coronary Artery via Mac-1, but not LFA-1, and ICAM-1Journal of Molecular and Cellular Cardiology, 1996
- Monoclonal Antibodies That Block the Activity of Leukocyte Function-associated Antigen 1 Recognize Three Discrete Epitopes in the Inserted Domain of CD11aPublished by Elsevier ,1995
- The A-domain of beta 2 integrin CR3 (CD11b/CD18) is a receptor for the hookworm-derived neutrophil adhesion inhibitor NIF.The Journal of cell biology, 1994
- ICAM-1 (CD54): a counter-receptor for Mac-1 (CD11b/CD18).The Journal of cell biology, 1990
- Cooperative interactions of LFA-1 and Mac-1 with intercellular adhesion molecule-1 in facilitating adherence and transendothelial migration of human neutrophils in vitro.Journal of Clinical Investigation, 1989
- Oligospecificity of the cellular adhesion receptor Mac-1 encompasses an inducible recognition specificity for fibrinogen.The Journal of cell biology, 1988
- Reduction of experimental canine myocardial reperfusion injury by a monoclonal antibody (anti-Mo1, anti-CD11b) that inhibits leukocyte adhesion.Journal of Clinical Investigation, 1988
- Anti-Mac-1 selectively inhibits the mouse and human type three complement receptor.The Journal of Experimental Medicine, 1982